226 related articles for article (PubMed ID: 12769160)
1. The need for tighter control of cardiovascular risk factors in diabetic patients.
Viberti G
J Hypertens Suppl; 2003 Mar; 21(1):S3-6. PubMed ID: 12769160
[TBL] [Abstract][Full Text] [Related]
2. Microalbuminuria: a common, independent cardiovascular risk factor, especially but not exclusively in type 2 diabetes.
Donnelly R; Yeung JM; Manning G
J Hypertens Suppl; 2003 Mar; 21(1):S7-12. PubMed ID: 12769161
[TBL] [Abstract][Full Text] [Related]
3. [Epidemiology of cardio-vascular complications of diabetes].
Grimaldi A; Heurtier A
Diabetes Metab; 1999 Jun; 25 Suppl 3():12-20. PubMed ID: 10421988
[TBL] [Abstract][Full Text] [Related]
4. New treatment guidelines for a patient with diabetes and hypertension.
Mogensen CE
J Hypertens Suppl; 2003 Mar; 21(1):S25-30. PubMed ID: 12769164
[TBL] [Abstract][Full Text] [Related]
5. [What do large clinical trials learn us about cardiovascular and renal prevention in patients with type 2 diabetes mellitus and hypertension?].
Dussol B; Berland Y
Nephrol Ther; 2006 May; 2(2):51-74. PubMed ID: 16895717
[TBL] [Abstract][Full Text] [Related]
6. [Arterial hypertension and dyslipidemia in patients with chronic kidney disease (CKD). Anti-platelet aggregation. Goal oriented treatment].
Cases Amenós A; Goicoechea Diezhandiño M; de Alvaro Moreno F
Nefrologia; 2008; 28 Suppl 3():39-48. PubMed ID: 19018737
[TBL] [Abstract][Full Text] [Related]
7. Use of losartan in diabetic patients in the primary care setting: review of the results in LIFE and RENAAL.
Egan B; Gleim G; Panish J
Curr Med Res Opin; 2004 Dec; 20(12):1909-17. PubMed ID: 15701209
[TBL] [Abstract][Full Text] [Related]
8. Left ventricular hypertrophy versus chronic kidney disease as predictors of cardiovascular events in hypertension: a Greek 6-year-follow-up study.
Tsioufis C; Vezali E; Tsiachris D; Dimitriadis K; Taxiarchou E; Chatzis D; Thomopoulos C; Syrseloudis D; Stefanadi E; Mihas C; Katsi V; Papademetriou V; Stefanadis C
J Hypertens; 2009 Apr; 27(4):744-52. PubMed ID: 19516174
[TBL] [Abstract][Full Text] [Related]
9. Long-term follow-up after tight control of blood pressure in type 2 diabetes.
Holman RR; Paul SK; Bethel MA; Neil HA; Matthews DR
N Engl J Med; 2008 Oct; 359(15):1565-76. PubMed ID: 18784091
[TBL] [Abstract][Full Text] [Related]
10. Concomitant macro and microvascular complications in diabetic nephropathy.
Alwakeel JS; Al-Suwaida A; Isnani AC; Al-Harbi A; Alam A
Saudi J Kidney Dis Transpl; 2009 May; 20(3):402-9. PubMed ID: 19414942
[TBL] [Abstract][Full Text] [Related]
11. Twelve shifting paradigms in diabetic renal disease and hypertension.
Mogensen CE
Diabetes Res Clin Pract; 2008 Nov; 82 Suppl 1():S2-9. PubMed ID: 18947897
[TBL] [Abstract][Full Text] [Related]
12. Reduction in albuminuria translates to reduction in cardiovascular events in hypertensive patients with left ventricular hypertrophy and diabetes.
Ibsen H; Olsen MH; Wachtell K; Borch-Johnsen K; Lindholm LH; Mogensen CE
J Nephrol; 2008; 21(4):566-9. PubMed ID: 18651547
[TBL] [Abstract][Full Text] [Related]
13. Relation of electrocardiographic left ventricular hypertrophy to blood pressure, body mass index, serum lipids and blood sugar levels in adult Nigerians.
Opadijo OG; Omotoso AB; Akande AA
Afr J Med Med Sci; 2003 Dec; 32(4):395-9. PubMed ID: 15259925
[TBL] [Abstract][Full Text] [Related]
14. Epidemiology and risk factors of macrovascular disease in diabetes mellitus.
Janka HU
Horm Metab Res Suppl; 1990; 22():8-11. PubMed ID: 2202634
[TBL] [Abstract][Full Text] [Related]
15. [Dyslipidemia and cardiovascular risk in type 2 diabetes mellitus patients with associated diabetic nephropathy].
Martínez-Castelao A; Ramos R; González MT; Castiñeiras MJ
Nefrologia; 2002; 22 Suppl 1():51-8. PubMed ID: 11987671
[TBL] [Abstract][Full Text] [Related]
16. Relationship between the achieved blood pressure and the incidence of cardiovascular events in Japanese hypertensive patients with complications: a sub-analysis of the CASE-J trial.
Ogihara T; Saruta T; Rakugi H; Fujimoto A; Ueshima K; Yasuno S; Oba K; Takeda K; Higaki J; Nakao K;
Hypertens Res; 2009 Apr; 32(4):248-54. PubMed ID: 19347033
[TBL] [Abstract][Full Text] [Related]
17. Predictors of mortality in patients with type 2 diabetes with or without diabetic nephropathy: a follow-up study.
Astrup AS; Nielsen FS; Rossing P; Ali S; Kastrup J; Smidt UM; Parving HH
J Hypertens; 2007 Dec; 25(12):2479-85. PubMed ID: 17984670
[TBL] [Abstract][Full Text] [Related]
18. ESH-ESC guidelines for the management of hypertension.
Erdine S; Ari O; Zanchetti A; Cifkova R; Fagard R; Kjeldsen S; Mancia G; Poulter N; Rahn KH; Rodicio JL; Ruilope LM; Staessen J; van Zwieten P; Waeber B; Williams B
Herz; 2006 Jun; 31(4):331-8. PubMed ID: 16810473
[TBL] [Abstract][Full Text] [Related]
19. Close association between parathyroid hormone and left ventricular function and structure in end-stage renal failure patients under maintenance hemodialysis.
Nasri H; Baradaran A; Naderi AS
Acta Med Austriaca; 2004 Aug; 31(3):67-72. PubMed ID: 15515479
[TBL] [Abstract][Full Text] [Related]
20. Clusters of metabolic risk factors predict cardiovascular events in hypertension with target-organ damage: the LIFE study.
de Simone G; Olsen MH; Wachtell K; Hille DA; Dahlöf B; Ibsen H; Kjeldsen SE; Lyle PA; Devereux RB
J Hum Hypertens; 2007 Aug; 21(8):625-32. PubMed ID: 17476291
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
